IP Library Patent Application 11105309
Patent Application
App. No. 11/105,309

Antigenic neisserial peptides

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/105,309
Abstract

WO99/24578 discloses a large number of proteins from Neisseria meningitidis and Neisseria gonorrhoeae . The present invention relates to fragments of those proteins which comprise at least one antigenic determinant. Homologous sequences and proteins comprising these fragments are also disclosed.

Claims (20)

1 . A fragment of a protein disclosed in WO99/24578, wherein the fragment comprises at least one antigenic determinant.

2 . The fragment of claim 1 , having a length of 100 amino acids or less.

3 . The fragment of claim 1 having a length of 3 amino acids or greater.

4 . The fragment of claim 1 , being one of the 14151 fragments of Table 1.

5 . A polypeptide having 50% or greater sequence identity to the fragment of any preceding claim.

6 . A protein comprising one or more fragment of claim 1 , claim 2 or claim 3 , with the proviso that the protein is not one of the 446 complete protein sequences disclosed in WO99/24578.

7 . An antibody which recognises the fragment according to claim 1 .

8 . A protein comprising a peptide sequence, wherein the peptide sequence is recognised by an antibody according to claim 7 .

9 . Nucleic acid encoding the fragment of claim 1 , claim 2 or claim 3 .

10 . A composition comprising the fragment of claim 1 , claim 2 or claim 3 .

11 . (canceled)

12 . (canceled)

13 . A method of treating a patient, comprising administering to the patient a therapeutically effective amount of a composition according to claim 10 .

14 . The fragment of claim 2 , having a length of 3 amino acids or greater.

15 . Nucleic acid encoding the polypeptide of claim 5 .

16 . Nucleic acid encoding the protein of claim 8 .

17 . A composition comprising the antibody of claim 7 .

18 . A composition comprising the nucleic acid of claim 9 .

19 . A method for treating a patient, comprising administering to the patient a therapeutically effective amount of a composition according to claim 17 .

20 . A method for treating a patient, comprising administering to the patient a therapeutically effective amount of a composition according to claim 18.

Assignments (1)
CHANGE OF NAME Recorded May 27, 2009
From: CHIRON SRL
To: NOVARTIS VACCINES AND DIAGNOSTICS SRL
Reel/Frame 022741/0937 →